Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Weekly
Analytics
Innovation and Product Development news
(page 12)
26 October 2025
Hyundai and Toray Partner on Advanced Mobility Materials
The firms signed a joint agreement to develop advanced composite materials for future mobility, focusing on R&D, production, and commercialization.
24 October 2025
Johnson & Johnson: Nipocalimab Reduces Sjögren’s Disease Activity and Severity
Nipocalimab shows promise in reducing Sjögren’s disease symptoms and autoantibodies, with a favorable safety profile and ongoing Phase 3 trials.
24 October 2025
Merus Reports Positive Interim Data on Petosemtamab in Metastatic Colorectal Cancer
Petosemtamab shows promising response rates in 1L and 2L mCRC, with potential as a new standard of care.
24 October 2025
Croda's Natrineo CR8 Wins Silver at Pure Beauty Awards
Natrineo CR8, a natural emulsifier, enhances skin hydration and sun care. It's 92% natural, biodegradable, and supports sustainable palm oil, aligning with modern beauty values.
24 October 2025
Johnson & Johnson's Icotrokinra Shows Promising Long-Term Results for Scalp and Genital Psoriasis
Icotrokinra achieves high skin clearance rates in difficult psoriasis areas over 52 weeks, maintaining safety and efficacy in both adults and adolescents.
24 October 2025
AGC and NPC Partner for Solar Panel Glass Recycling Expansion
Aiming to recycle solar panel glass by 2030, a new method turns cover glass into architectural glass, overcoming technical challenges and enhancing sustainability.
News type
New Projects and Expansions
New Projects and Expansions
Project Updates and Milestones
Project Updates and Milestones
Mergers, Acquisitions, and Partnerships
Mergers, Acquisitions, and Partnerships
Innovation and Product Development
Innovation and Product Development
Operational Changes and Investments
Operational Changes and Investments
Sustainability and Environmental Initiatives
Sustainability and Environmental Initiatives
Financial Performance and Strategy
Financial Performance and Strategy
Executive Appointments and Governance Changes
Executive Appointments and Governance Changes
Regulatory and Compliance Updates
Regulatory and Compliance Updates
Workforce and Corporate Social Responsibility (CSR)
Workforce and Corporate Social Responsibility (CSR)
Crisis and Risk Management
Crisis and Risk Management
The right choices in the European chemical industry
Save time with
chemXplore Analytics
Learn more
24 October 2025
Evonik Opens New Aluminum Specialty Plant in Japan
Evonik's new plant in Japan boosts local production of advanced fumed alumina, enhancing supply security, sustainability, and customer proximity in Asia.
24 October 2025
Kemira Oyj Q3 2025: Profitability Steady Amid Market Challenges
Revenue and EBITDA declined due to market softness. Water Solutions remained strong. Strategic acquisitions and partnerships aim to boost growth. 2025 outlook remains unchanged.
24 October 2025
Holcim Reports Continued Profitable Growth
Recurring EBIT up 9.8%, net sales up 2.9%. Acquiring Xella to boost sustainable walling systems. FY2025 guidance confirmed, aligning with NextGen Growth 2030 targets.
23 October 2025
Elkem Launches Biocompatible, Conductive Silicone for Healthcare Devices
Elkem's new silicone offers high conductivity, biocompatibility, and process control for medical devices, enhancing performance and sustainability in healthcare applications.
23 October 2025
EIB Invests €40M in Meva Energy for Biogas Innovation
EIB funds will help scale modular biogas plants, supporting EU climate goals by converting biomass into renewable energy and promoting industrial decarbonization.
23 October 2025
Evonik Launches Noblyst® F Catalysts for Flow Applications
Noblyst® F catalysts, based on carbon granules, offer two particle sizes for flow applications. Evonik explores more options to support continuous processing in pharma and fine chemicals.
23 October 2025
Merck's KEYTRUDA and KEYTRUDA QLEX Get FDA Priority Review for Bladder Cancer Treatment
FDA grants priority review for KEYTRUDA combinations with Padcev, showing improved survival in muscle-invasive bladder cancer patients ineligible for cisplatin-based chemotherapy.
23 October 2025
Cytiva Launches Renewable Polyolefins
Cytiva adopts renewable polypropylene to cut Scope 3 emissions, ensuring high performance in healthcare applications with ISCC PLUS-certified materials.
23 October 2025
NEXTCHEM Secures Engineering Contract with newcleo for Modular Nuclear Plant Design
NEXT-N to design a nuclear plant's conventional island, leveraging MAIRE's expertise, aiming for carbon-neutral chemistry with hydrogen and ammonia integration.
23 October 2025
Asahi Kasei Expands Electrolysis Component Production for Clean Hydrogen
New facilities at Kawasaki Works will boost production of electrolysis components, supporting clean hydrogen and chlor-alkali markets, backed by Japan's GX Supply Chain Development Program.
22 October 2025
Boehringer Ingelheim's JASCAYD® Approved in China for IPF Treatment
Nerandomilast, approved in China for IPF, showed significant lung function improvement in Phase III trials. It offers favorable tolerability and is also FDA-approved in the U.S.
22 October 2025
Symrise Invests in Cellibre to Boost Innovation in Taste and Cosmetic Markets
Symrise gains access to Cellibre's fermentation tech for scalable, sustainable ingredient production, enhancing supply chain resilience and aligning with sustainability goals.
22 October 2025
EnviTec Biogas AG Wins 2025 Energy Vision Leadership Award
EnviTec recognized for advancing clean energy and circular economy, with notable projects like Germany's largest bio-LNG plant, Güstrow, highlighting economic and environmental benefits.
21 October 2025
Rely Joins TNO VoltaChem's Anion Exchange Membrane Electrolyser Program
The program aims to advance AEM electrolysers, focusing on safety, energy management, and cost efficiency, using PGM-free technology for sustainable hydrogen production.
21 October 2025
Takeda Partners with Innovent on Oncology Medicines
Takeda gains rights to two late-stage cancer drugs and an option for an early-stage program, focusing on global development and commercialization outside Greater China.
21 October 2025
Veolia to Operate Chile's First Desalination Plant in Valparaíso
Veolia wins a four-year contract to manage a desalination plant and aqueduct in Chile, focusing on renewable energy and local labor, with potential extensions until 2040.
21 October 2025
BASF and IFF Collaborate on Enzyme and Polymer Innovation
The collaboration aims to develop sustainable enzyme and polymer technologies for cleaning and personal care, enhancing performance and reducing environmental impact.
21 October 2025
Evonik Unveils GMP-Grade EUDRACAP® Colon Capsules at CPHI Frankfurt
EUDRACAP® colon capsules enable precise delivery of sensitive actives to the ileo-colonic region, simplifying drug development and accelerating market entry for innovative therapies.
21 October 2025
Borealis and Promix: Recyclable Packaging for PPWR Compliance
Developed recyclable packaging with Borcycle™ M and Promix Microcell Technology, meeting EU's 2030 PPWR targets for recyclability and recycled content in non-food applications.
20 October 2025
NEXTCHEM to Conduct Feasibility Study for Waste-to-Methanol Project in Norway
The project explores converting waste to low-carbon methanol at Mongstad, aiding compliance with EU regulations for marine and aviation fuels.
20 October 2025
Lummus Technology Secures Consecutive Technology Licensor of the Year Award
Lummus also won Best Refining Technology for CDDMESM. They were finalists in four other categories, highlighting their innovation and leadership in the energy sector.
20 October 2025
Merck Begins $3B Pharmaceutical Facility Construction in Virginia
Merck invests $70B in U.S. manufacturing and R&D, creating 500+ full-time and 8,000 construction jobs in Virginia, enhancing biopharmaceutical innovation and domestic production.
20 October 2025
Johnson & Johnson's INLEXZO™ and Cetrelimab Show Promising Pre-Surgical Results in Bladder Cancer
Phase 2b study shows INLEXZO™ plus cetrelimab achieves significant pathologic response rates in muscle invasive bladder cancer patients ineligible for platinum-based chemotherapy.
20 October 2025
Novo Nordisk to Present Oral Semaglutide and Obesity Data at ObesityWeek 2025
New data on oral semaglutide and CagriSema will be presented, focusing on weight loss efficacy, cardiometabolic health, and women's health in obesity management.
← Previous
Next →
